Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus vaginalis capsule plus metronidazole for prevention of recurrent bacterial vaginosis
CTR20181748Phase 2Completed
- Sponsor
- Osaweike Biopharma
- Start
- Oct 2018
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus vaginalis in bacterial vaginosis (BV), sponsored by Osaweike Biopharma. Started Oct 2018; status: completed.
02
Drugs
lactobacillus vaginalis
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20181748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181748.